10Aug 2017

PROGNOSTICATION OF NF-ΚB AND P53 EXPRESSION IN DIFFERENT STAGE AND GRADE OF OVARIAN CANCER.

  • Department of Gynecology & Obstetrics, Institute of Post-Graduate Medical Education and Research, A.J.C. Bose Road, Kolkata-700020, West Bengal, India
  • Centre for research in nanoscience & nanotechnology, acharya prafulla chandra roy sikhsha prangan, university of Calcutta, jd-2, sector 3, salt lake city, kolkata-700108, West Bengal, India.
Crossref Cited-by Linking logo
  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

Introduction: Incidence of ovarian cancer is increasing in female population in urban India. Till now most of the treatments are guided by the tumor parameters and many occasions the results of treatment have been unpredictable. This study aims to various molecular factors and will try to link then with the tumor factors. This study was evaluated prognostic significance of like NF-κB and p53 expression in ovarian cancer patients. Material and Methods: In this hospital based study 106 ovarian cancer patients attend at OPD in our institute of Eastern India. NF-κB and p53 protein expression was measured from cancer tissue sample by both Western Blot and RT-PCR Technique. For statistical analysis data were entered into a Microsoft excel spreadsheet and then analyzed by SPSS 20.0.1 and Graph Pad Prism version 5. Results: NF-κB was overexpressed with 66(66.2%) patients and p53 was activated with 69(65.21%) patients in ovarian carcinoma in Indian population. Statistically significant associations of NF-κB and p53 positive tumors were found in advance stage, grade, histopathology type and lymph node metastasis. It was showed that poor prognostic outcome was observed in NF-κB and p53 activated ovarian cancer patients. Conclusions: It was concluded NF-κB and p53 is an independent prognostic and predictive marker of Indian ovarian cancer. Thus the study can in a pioneering work in establishing new risk stratification system which will be an importance selecting appropriate adjuvant therapy following surgery. No such host-tumor integrating study has come out from this subcontinent and therefore is be of importance in establishing ovarian cancer patient?s guideline for general Indian population.

  1. Basu P., De P., Mandal S., Ray K., Biswas J.,?Study of ?patterns of care? of ovarian cancer patients in a specialized cancer institute in Kolkata, eastern India,?Indian Journal of Cancer, vol. 46, no. 1, pp. 28-33, 2009.
  2. Jemal A., Siegel R., Ward E., Murray T., Xu J., Smigal C., et al,?Cancer statistics, 2006,?CA Cancer J Clin, vol. 56, no. 2, pp. 106-130, 2006.
  3. Jana, S. Mandal, M. Mukhopadhyay, D. Mitra, S. K Mukhopadhyay, D. K. Sarkar,?Prognostic Significance of HER-2/neu and Survival of Breast Cancer Patients Attending a Specialized Breast Clinic in Kolkata, Eastern India,? Asian Pacifc J Cancer Prev, vol. 13, no. 8, pp. 3851-3855, 2012.
  4. Legge, G. Ferrandina, V. Salutari& G. Scambia,?Biological characterization of ovarian cancer: prognostic and therapeutic implications,? Annals of Oncology, vol. 16 no. 4, pp. iv95?iv101, 2005.
  5. Yang, X. Xiao, D. G. Rosen, X. Cheng, X. Wu, B. Chang, et al,? The Biphasic Role of NF-kB in Progression and Chemoresistance of Ovarian Cancer,? Clin Cancer Res, vol. 17, no. 8, pp. 2181?2194,? 2011.
  6. Vollan H.K., Rueda O.M., Chin S.F., Curtis C., Turashvili G., Shah .S, et al, ?A tumor DNA complex aberration index is an independent predictor of survival in breast and ovarian cancer,? MolOncol, vol. 9, no. 1, pp. 115-27, 2015.
  7. Chen, Y. Jin, Y. Bi, Y. Li, Y. Shan, L. Pan,?Prognostic Significance of Lymphovascular Space Invasion in Epithelial Ovarian Cancer,?Journal of Cancer, vol. 6, no. 5,pp. 412-419, 2015.
  8. Sethi and V. Tergaonkar,?Potential pharmacological control of the NF-kB pathway,? Cell, vol. 30, no. 6,pp. 313-321, 2009.
  9. James T. Wu and John G. Kral,?The NF-κB/IκB Signaling System: A Molecular Target in Breast Cancer Therapy,? Journal of Surgical Research, vol. 123, no 1, pp. 158?169, 2005.
  10. F. Chen and W.C. Greene,?Shaping the nuclear action of NF-kappaB,?Nature Rev, vol. 5, no. 5, pp. 392?401, 2004.
  11. Fradet V, Lessard L, B?gin LR, Karakiewicz P, Masson AM and Saad F,?Nuclear factor-kappaB nuclear localization is predictive of biochemical recurrence in patients with positive margin prostate cancer,?Clin Cancer Res, vol. 10, no. 24, pp. 8460-8464, 2004.
  12. Ross JS, Kallakury BV, Sheehan CE, Fisher HA, Kaufman RP Jr, Kaur P, et al, ?Expression of nuclear factor-kappa B and I kappa B alpha proteins in prostatic adenocarcinomas: correlation of nuclear factor-kappa B immunoreactivity with disease recurrence,?Clin Cancer Res, vol. 10, no. 7, pp. 2466-2472, 2004.
  13. Kleinberg L, Dong HP, Holth A, RisbergB, Trope' CG, Nesland JM, et al,?Cleaved caspase-3 and nuclear factor-kappaB p65 are prognostic factors in meta-static serous ovarian carcinoma,?Hum Pathol, vol. 40, no. 6, pp. 795-806, 2009.
  14. C. Gupta, C. Undaram, S. Reuter, B. B Aggarwal,?Inhibiting NF-κB activation by small molecules as a therapeutic strategy,? BiochimicaBiophysicaActa, vol. 1799, no. 10-12,pp. 775?787, 2010.
  15. R. Greten and M. Karin,?The IKK/NF-κB activation pathway?a target for prevention,?Cancer Letters, vol. 206, no. 2, pp. 193?199, 2004.
  16. Jana, S. Das, D. K. Sarkar, S. Mandal, A. Maji, M. Mukhopadhyay,?Role of Nuclear Factor-κB in female Breast Cancer: A Study in Indian Patients?Asian Pacifc J Cancer Prev,vol. 13, no. 11, pp. 5511-5515, 2012.
  17. Annunziata CM, Stavnes HT, Kleinberg L, Berner A, Hernandez LF, Birrer MJ, et al,?NF-κB transcription factors are co-expressed and convey poor outcome in ovarian cancer,? Cancer, vol. 116, no. 13, pp, 3276?3284, 2010.
  18. Yang G, Xiao X, Rosen DG, Cheng X, Wu X, Chang B, et al,?The Biphasic Role of NF-κB in Progression and Chemoresistance of Ovarian Cancer,? Clin Cancer Res,vol. 17, no. 8, pp. 2181?2194, 2011.
  19. Kleinberg L, Dong HP, Holth A, RisbergB, Trope? CG, Nesland JM, et al,?Cleaved caspase-3 and nuclear factor-kappaB p65 are prognostic factors in metastatic serous ovarian carcinoma,? Hum Pathol, vol. 40, no. 6, pp. 795?806, 2009.
  20. Annunziata CM, Stavnes HT, Kleinberg L, Berner A, Hernandez LF, Birrer MJ, et al,?Nuclear factor kappaB transcription factors are coexpressed and convey a poor outcome in ovarian cancer,? Cancer, Vol.116, no. 13, pp. 3276?3284, 2010.
  21. Sarkar DK, Jana D, Patil PS, Chaudhari KS, Chattopadhyay BK, Chikkala BR, ?Role of NF-κB as a Prognostic Marker in Breast Cancer: A Pilot Study in Indian Patients,?Indian J SurgOncol, 13, no. 3, pp. 0234-0238, 2013.
  22. L C Hartmann, K C Podratz, G L Keeney, N A Kamel, J H Edmonson, J P Grill, et al, ?Prognostic significance of p53 immunostaining in epithelial ovarian cancer,?Journal of Clinical Oncology, vol. 12, no. 1,pp.64-69, 1994
  23. Ravi, A. Bedi,?NF-κB in cancer?a friend turned foe,?Drug Resistance Updates , vol. 7, no. 1,pp. 53?67, 2004.
  24. Rocha, S., Martin, A.M., Meek, D.W., Perkins, N.D., ?p53 represses cyclin D1 transcription through down regulation of Bcl-3 and inducing increased association of the p52 NF-kappaB subunit with histone deacetylase,? Cell Biol, vol. 23, no. 13, pp. 4713?4727, 2003.
  25. Ikeda A, Sun X, Li Y, Zhang Y, Eckner R, Doi TS, et al., ?p300/CBP-dependent and independent transcriptional interference between NF-kappaBRelA and p53,? Biochem. Biophys. Res. Commun, vol. 272, no. 2, pp. 375?379, 2000.
  26. Tergaonkar, V., Pando, M., Vafa, O., Wahl, G., Verma, I.,?p53 stabilization is decreased upon NFkappaB activation: a role for NFkappaB in acquisition of resistance to chemotherapy,?Cancer Cell, vol. 1, no. 5, pp. 493?503, 2002.

[Debarshi Jana, Sambhunath Bandyopadhyay, Priyanka Upadhyay, Arghya Adhikary and Asim Kumar Manna. (2017); PROGNOSTICATION OF NF-ΚB AND P53 EXPRESSION IN DIFFERENT STAGE AND GRADE OF OVARIAN CANCER. Int. J. of Adv. Res. 5 (Aug). 603-610] (ISSN 2320-5407). www.journalijar.com

Dr. Debarshi Jana
INSTITUTE OF POST GRADUATE MEDICAL EDUCATION & RESEARCH (IPGME&R) AND SETH SUKHLAL KARNANI MEMORIAL HOSPITAL (SSKM), KOLKATA-700020, WEST BENGAL, INDIA.

DOI:

Article DOI: 10.21474/IJAR01/5095      
DOI URL: http://dx.doi.org/10.21474/IJAR01/5095

Download Full Paper

Download PDF No. of Downloads: 14 | No. of Views: 86